Core Viewpoint - Jiangsu Hualan Pharmaceutical New Materials Co., Ltd. plans to repurchase its shares using raised funds, self-owned funds, and self-raised funds through centralized bidding, with a total repurchase amount between RMB 100 million and RMB 200 million [1][2]. Summary by Sections Share Repurchase Plan - The company will use a total of no less than RMB 100 million and no more than RMB 200 million for the share repurchase, with raised funds accounting for no less than RMB 70 million and no more than RMB 140 million [2]. - The maximum repurchase price is set at RMB 45.50 per share, with the repurchase period not exceeding 12 months from the date of shareholder meeting approval [2]. Adjustments Post-Equity Distribution - Following the implementation of the 2024 annual equity distribution, the maximum repurchase price will be adjusted to RMB 34.84 per share, effective from July 14, 2025 [3]. - The repurchase will include shares for employee stock ownership plans or equity incentives, with specific quantities and funding sources detailed in the report [3][4]. Debt Creditor Information - Creditors have the right to request debt repayment or guarantees within 30 days of notification or 45 days from the announcement date, with the company continuing to fulfill obligations as per original debt agreements [4][5]. - Required materials for debt claims include contracts and identification documents, with specific submission methods outlined [5].
华兰股份: 关于回购股份减少注册资本通知债权人的公告